Source: Eur Respir J 2008; 32: 1399-1403
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Colombat M., Caudroy S., Lagonotte E., Mal H., Danel C., Stern M., Fournier M., Birembaut P.. Pathomechanisms of cyst formation in pulmonary light chain deposition disease. Eur Respir J 2008; 32: 1399-1403

Member's Comments

No comment yet.

Related content which might interest you: High MMP-9 activity characterises pleural tuberculosis correlating with granuloma formation Source: Eur Respir J 2009; 33: 134-141 Year: 2009 Lysyl oxidases in idiopathic pulmonary fibrosis: A key participant in collagen I matrix remodelling Source: International Congress 2015 – Airway remodelling: recent developments Year: 2015 Correlations of collagen matrix between nonspecific interstitial pneumonia and collagen disease - preliminary study Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005 The activity of the inflammatory process and markers of an extracellular matrix destruction in pulmonary tuberculoma Source: Virtual Congress 2020 – Mechanistic insight into lung injury and repair Year: 2020 Collagen phagocytosis by lung alveolar macrophages in animal models of emphysema Source: Eur Respir J 2003; 22: 728-734 Year: 2003 The role of matrix metalloproteinases in cystic fibrosis lung disease Source: Eur Respir J 2011; 38: 721-727 Year: 2011 Pivotal clinical dilemmas in collagen vascular diseases associated with interstitial lung involvement Source: Eur Respir J 2009; 33: 882-896 Year: 2009 Role of matrix metalloproteinases in progression of idiopathic pulmonary fibrosis Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Pulmonary light chain deposition disease: a retrospective analysis of 11 cases Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases Year: 2019 Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2005; 25: 834-842 Year: 2005 Utilisation of whole slide image analysis to quantify lesion formation, collagen content and cell density within histologically stained fibrotic lung tissue Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016 Alternative Polyadenylation(APA) modulates extracellular matrix deposition in pulmonary hypertension Source: ERS Lung Science Conference 2018 Year: 2018 Tranilast inhibits pulmonary fibrosis by suppressing TGFbeta-mediated extracellular matrix protein production Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013 Matrix metalloproteinases and their inhibitors in pulmonary hypertension}, Source: Eur Respir J 2012; 40: 766-782 Year: 2012 Collagen V activation and matrix extracellular remodeling mediated pulmonary fibrosis in experimental models of bleomycin and 3-5-di-tert-4-hidroxitoluene Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Interaction of matrix metalloproteinases with pulmonary pollutants Source: Eur Respir J 2012; 39: 1021-1032 Year: 2012 Remodelling in the bronchi of patients with COPD: defective ECM deposition and repair by pulmonary fibroblasts Source: Annual Congress 2013 –Immunopathology of COPD: contribution of advancements of new therapeutic agents Year: 2013 Severe interstitial lung disease in connective tissue disease: rituximab as rescue therapy}, Source: Eur Respir J 2012; 40: 641-648 Year: 2012 Type V collagen induced pulmonary fibrosis in C57Bl/6mice Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 System of matrix metalloproteinases in infiltrative pulmonary tuberculosis (with and without lung tissue destruction) Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015